Company: IMNN
Filing Date: 2025-05-19
Form Type: S-1/A
Source: 0001641172-25-011388
Chunk: 42

Company: Imunon, Inc.
Filing Date: 2025-05-19
Form: S-1/A
Chunk 42
---
 Company files a Current Report on Form 8-K with the SEC giving public notice of Stockholder Approval.

“ Floor Price” means a price per share equal to $0.10 (based on an assumed public offering price of $0.48 per share), which represents 20% of the public offering price per share.

| 19 |

Exercisability

The common warrants will be exercisable beginning on the Initial Exercise Date, at the option of each holder, in whole or in part, by delivering a duly executed exercise notice accompanied by payment in full for the number of shares of our Common Stock purchased upon such exercise (except in the case of a cashless exercise as discussed below). A holder (together with its affiliates) may not exercise any portion of the common warrant to the extent that the holder would own more than 4.99% (or, at the election of the holder, 9.99%) of the outstanding Common Stock immediately after exercise, except that upon at least 61 days’ prior notice from the holder to us, the holder may increase or decrease the Beneficial Ownership Limitation to a percentage not to exceed 9.99%. No fractional shares of Common Stock will be issued in connection with the exercise of a common warrant. In lieu of fractional shares, we will round down to the next whole share of Common Stock. The common warrants will expire two and one-half (2.5) years after the Initial Exercise Date.

Cashless Exercise and Zero Exercise Price Exercise

If, at the time
a holder exercises its common warrants, a registration statement registering the issuance of the shares of Common Stock underlying the
common warrants under the Securities Act is not then effective or available for the issuance of such shares, then in lieu of making the
cash payment otherwise contemplated to be made to us upon such exercise in payment of the aggregate exercise price, the holder may elect
instead to receive upon such exercise (either in whole or in part) the net number of shares of Common Stock determined according to a
formula set forth in the common warrants.

Holders may also effect a “zero exercise price” exercise at any time while the common warrants are outstanding following the Initial Exercise Date. Under the zero exercise price option, a holder of a common warrant has the right to receive an aggregate number of shares equal to the product of (i) the aggregate number of shares of Common Stock that would be issuable upon a cash rather than a cashless exercise of the common warrant and (ii) 3.0,